summary: search

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). The ANDAs sought approval to market generic versions of SEROQUEL(R) (quetiapine fumarate) tablets in the US before SEROQUEL's patent expires in 2011. Since the Court granted AstraZeneca's motion for Summary Judgment of No Inequitable Conduct in its entirety, trial is unnecessary.

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca AZN today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). The ANDAs sought approval to market generic versions of SEROQUEL(R) (quetiapine fumarate) tablets in the US before SEROQUEL's patent expires in 2011. Since the Court granted AstraZeneca's motion for Summary Judgment of No Inequitable Conduct in its entirety, trial is unnecessary.

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca AZN today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). The ANDAs sought approval to market generic versions of SEROQUEL(R) (quetiapine fumarate) tablets in the US before SEROQUEL's patent expires in 2011. Since the Court granted AstraZeneca's motion for Summary Judgment of No Inequitable Conduct in its entirety, trial is unnecessary.

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). The ANDAs sought approval to market generic versions of SEROQUEL(R) (quetiapine fumarate) tablets in the US before SEROQUEL's patent expires in 2011. Since the Court granted AstraZeneca's motion for Summary Judgment of No Inequitable Conduct in its entirety, trial is unnecessary.

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN - News) today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). The ANDAs sought approval to market generic versions of SEROQUEL® (quetiapine fumarate) tablets in the US before SEROQUEL's patent expires in 2011. Since the Court granted AstraZeneca's motion for Summary Judgment of No Inequitable Conduct in its entirety, trial is unnecessary.

Plunkett's Guide to Nanosphere, Inc. (NSPH) & the Nanotechnology Industry 2008 (Summary)

This summary contains complete trends chapters excerpted from Plunkett's Nanotechnology and MEMS Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends affecting the industry today. In addition, we provide a comprehensive profile of Nanosphere, Inc. (NSPH) including company contact information, financials, geographical locations, executive contacts and a detailed research analysis.

SUSE Security Summary Report SUSE-SR:2008:012

______________________________________________________________________________ SUSE Security Summary Report Announcement ID: SUSE-SR:2008:012 Date: Fri, 06 Jun 2008 16:00:00 +0000 Cross-References: CVE-2008-0073, CVE-2008-1419, CVE-2008-1420 CVE-2008-1423, CVE-2008-1637, CVE-2008-1686 CVE-2008-1878, CVE-2008-2097, CVE-2008-2142 CVE-2008-2388, CVE-2008-2389 Content of this advisory: 1) Solved Security Vulnerabilities: - xine NSF buffer overflow - xemacs and emacs fast-lock file problems - opensuse-updater tmp problems and off-by-one problems - libvorbis security problems - xine sdpplin_parse overflow - vorbis-tools speex code execution problem - pdns-recursor spoofing problems - openwsman post-auth remote code execution 2) Pending Vulnerabilities, Solutions, and Work-Arounds: - kernel update 3) Authenticity Verification and Additional Info

PR Newswire Summary of Technology Copy, May 22, 2008

Following is a summary of high technology news releases transmitted today by PR Newswire. The full text of these releases is available at the PR Newswire for Journalists, http://media.prnewswire.com/.

PR Newswire Summary of Technology Copy, May 22, 2008 - StreetInsider.com (subscription)

The previous page is sending you to http://www.streetinsider.com/Press+Releases/PR+Newswire+Summary+of+Technology+Copy,+May+22,+2008/3681880.html.

AstraZeneca granted summary judgment in Seroquel patent litigation

AstraZeneca has announced that the US District Court of New Jersey has granted the company's motion for summary judgment of no inequitable conduct.

AstraZeneca says Summary Judgment Granted for SEROQUEL Patent Litigation - Quick Facts

(RTTNews) - AstraZeneca (AZN: News, Chart, Quote ) announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct.

Haynes and Boone Secures Summary Judgment In Toll Collection Technology Patent Case

News , Press Release and Blog Haynes and Boone Secures Summary Judgment In Toll Collection Technology Patent Case

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the US District Court for the District of

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

Hier finden Sie Nachrichten zu Ihrem Suchbegriff - Sie können den Zeitraum angeben oder auch Suchbegriffe kombinierenErweiterte Suche |

Summary Judgment Granted for SEROQUEL(R) Patent Litigation

PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the US District Court for the District of

Good Summary of Potential Video Game Monetization Methods

David Perry, Chief Creative Officer of Acclaim Games, has identified 29 possible ways to monetize video games in a recent CNET-article. There is nothing revolutionary here - the list includes Advertgames, Episodic Entertainment and Micro-Transactions. But the list illustrates an important point - the games industry (and all other mediums for that sake) has to diversify its revenue stream in the face of competition, piracy and the economy. Fortunately there are, at least, 29 ways of doing that readily available for developers. Looking forwards to a lively discussion about this topic at our upcoming NY Games Conference, where we have several panels dedicated to monetization. In the meantime, post a comment and let us know what you think of Perry's list.

A summary of new molecular microbial ecology tools - STAR SCIENCE By Francis L. de los Reyes III, PhD

wrote these words in the early 1990s, to herald the revolution occurring in microbiology. He was referring to the use of molecular methods, particularly the use of DNA and RNA sequence analysis as a framework for classifying organisms. Woese had earlier proposed the use of ribosomal RNA (rRNA) gene sequences as a major lens with which to view all of microbial life. In the last 20 years, rRNA analysis has radically changed microbial classification, microbial ecology, environmental microbiology, and evolutionary studies. Coupled with powerful techniques for copying, manipulating, and analyzing DNA and RNA, this molecular biological approach has turned the biological sciences inside out and upside down.

SUSE Security Summary Report SUSE-SR:2008:013

Broadband Service Provider Trident SR Sdn. Bhd.

Mississippi Daily Auction Summary MS

Home | World News | Latest News | Popular News | Company News | Cow Calf | Cattle Breeds | Cattle Feeding | Cattle Processing | Feeder Cattle | Beef Retail

Vodafone Data Wahehouse: the summary translated

A few days ago I posted about a Teradata Partners Conference, where Vodafone's Rachel Harrison will be speaking about Vodafone New Zealand's user retention project.

Discovery astronauts install Japanese module - Summary

Washington - Two NASA astronauts on Tuesday installed the Japanese module, Kibo, on the International Space Station in a nearly seven-hour spacewalk. During a six-hour, 48-minute excursion, space shuttle Discovery specialists Mike Fossum and Ron Garan attached the laboratory to the ISS, retrieved a shuttle inspection tool, and serviced and inspected solar components.

Updated and correct link to AMD Tech Day 2008 summary

Please note: comments that are inappropriate or promotional in nature will be deleted. E-mail addresses are not displayed, but you must enter a valid e-mail address to confirm your comments.

Over 1,000 strip off for US artist Tunick in Ireland - Summary

Cork, Ireland - Just over 1,000 people bared all at dawn Tuesday to pose for a photo installation by US artist Spencer Tunick at Blarney Castle near Cork, south-west Ireland, in what proved a liberating experience for most participants. Speaking to reporters afterwards, who had waited since 2 am, Tunick said he was pleased that more than the expected 800 participants had arrived.

Search took 0.02 seconds.